UPDATE 1-US FDA approves Bristol-Myers' lung cancer drug - Yahoo Finance

Retrieved on: 2023-11-15 22:18:38

Tags for this article:

Lung cancer

Breakthrough therapy

Orphan drugs

Tyrosine kinase receptors

Antineoplastic drugs

ROS1

Non-small-cell lung cancer

Nivolumab

Protein kinase inhibitor

Bristol-Myers Squibb

Small-cell carcinoma

Tyrosine kinase

Bristol-Myers Squibb's

Click the tags to see associated articles and topics

UPDATE 1-US FDA approves Bristol-Myers' lung cancer drug - Yahoo Finance. View article details on hiswai:

Excerpt

... Roche , Merck and AstraZeneca ... Roche , Merck and AstraZeneca. Repotrectinib belongs to a class of treatments known as tyrosine kinase inhibitors ...

Article found on: finance.yahoo.com

View Original Article